Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

People with sickle cell disorder and thalassaemia to get world-first NHS test

People with sickle cell disorder and thalassaemia to get world-first NHS test

The new ‘blood matching’ genetic test will reduce the risk of transfusion side effects while offering more personalised care for patients 

The UK’s National Health Service (NHS) has become the first healthcare system in the world to provide a new blood group genotyping test for people with rare inherited blood disorders.


From Monday (22 January), thousands of patients suffering from sickle cell disorder and thalassaemia will get access to the world-first ‘blood matching’ genetic test, which will help reduce their risk of transfusion side effects while offering more personalised care.

In England, it is estimated that around 17,000 people are living with sickle cell disorder, with 250 new cases reported each year, and there are about 800 thalassaemia patients, with less than 50 new cases a year.

Health Minister Andrea Leadsom said: “Thousands of people living with sickle cell disease and thalassaemia will be eligible for this new world-first blood test which is set to transform their care.

“This is a huge step forward in improving the quality of life for people who are living with these blood disorders. This is another example of the NHS leading the way in healthcare.”

Sickle cell disorder can cause severe organ damage and intense pain if damaged red blood cells block vessels and restrict oxygen supply.

Thalassaemia affects the production of haemoglobin, a protein used by red blood cells to carry oxygen around the body, resulting in severe anaemia, which can be fatal if not treated.

Life-saving transfusions are commonly used to treat these blood disorders, but around a fifth of patients develop antibodies against certain blood groups following transfusion.

The new test will help find the best compatible blood for patients with complex requirements, reduce the risk of developing transfusion reactions.

It will also benefit patients living with transfusion-dependent rare inherited anaemias, such as Diamond Blackfan anaemia, a disorder that affects the body’s ability to produce red blood cells.

Hence, NHS England, along with NHS Blood and Transplant, is encouraging patients with such inherited blood disorders to have this test taken alongside their routine hospital blood tests.

“Being able to provide high-quality and more personalised care to people with inherited blood disorders is an important step forward in helping to reduce health inequalities and this innovative test will greatly improve quality of life for people living with these disorders,” said Professor Bola Owolabi, Director of the National Healthcare Inequalities Improvement Programme at NHS England.

She has urged those eligible for the test to ask their clinical teams about it and to accept, if they are invited to take part.

More For You

St James's University Hospital , NHS

Care Quality Commission downgraded the maternity and neonatal services at St James's University Hospital and Leeds General Infirmary.

Getty images

Two Leeds maternity units downgraded after inspection

The NHS regulator has downgraded two hospitals in Leeds to "inadequate" from "good" following an inspection.

The Care Quality Commission (CQC) said the maternity and neonatal services at Leeds General Infirmary (LGI) and St James' University Hospital of the Leeds Teaching Hospitals (LTH) NHS Trust posed "a significant risk" to women and babies.

Keep ReadingShow less
Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less